Decreased hepatic enzymes reflect the decreased vitamin B6 levels in Parkinson's disease patients

Ikenaka, Kensuke; Kajiyama, Yuta; Aguirre, César; Choong, Chi Jing; Taniguchi, Seira; Doi, Junko; Wang, Nan; Ajiki, Takahiro; Ogawa, Kotaro; Kakuda, Keita; Kimura, Yasuyoshi; Mochizuki, Hideki

doi:https://doi.org/10.1002/prp2.1174

Decreased hepatic enzymes reflect the decreased vitamin B6 levels in Parkinson's disease patients

Ikenaka, Kensuke; Kajiyama, Yuta; Aguirre, César et al.

Pharmacology Research and Perspectives, 2024, 12(1), e1174

アクセス数:2,051件（2025-07-23 08:52 集計）

固定URL: https://hdl.handle.net/11094/94596

閲覧可能ファイル

ファイル	フォーマット	利用条件	サイズ	閲覧回数	利用開始日	説明	information
PharmacolResPerspect_12_1	pdf	なし	1.20 MB	86	2024.03.04

Creative Commons : 表示 - 非営利

論文情報

ファイル出力 EndNote Basic出力 Mendeley出力

タイトル	Decreased hepatic enzymes reflect the decreased vitamin B6 levels in Parkinson's disease patients
著者	NRID 1000070774058 1000070774058 researchmap permalink kensukeikenaka kensukeikenaka Scopus Author ID 8588484300 8588484300 著者名 Ikenaka, Kensuke
	NRID 1000080792390 1000080792390 ORCID 0000-0001-7170-0758 0000-0001-7170-0758 researchmap permalink ykajiyama ykajiyama 著者名 Kajiyama, Yuta
	NRID 1000020865597 1000020865597 researchmap permalink cesarderkatter cesarderkatter 著者名 Aguirre, César
	NRID 1000050796076 1000050796076 researchmap permalink choongcj choongcj 著者名 Choong, Chi Jing
	NRID 1000000894370 1000000894370 ORCID 0000-0002-5297-7716 0000-0002-5297-7716 researchmap permalink seirataniguchi seirataniguchi Scopus Author ID 57336847600 57336847600 著者名 Taniguchi, Seira
	NRID 1000050343728 1000050343728 researchmap permalink read0070576 read0070576 著者名 Doi, Junko
	著者名 Wang, Nan
	著者名 Ajiki, Takahiro
	NRID 1000080870500 1000080870500 researchmap permalink jihdiegisojosugudc jihdiegisojosugudc Scopus Author ID 57200553653 57200553653 著者名 Ogawa, Kotaro
	NRID 1000020815500 1000020815500 researchmap permalink keitakakuda keitakakuda Scopus Author ID 57192154985 57192154985 著者名 Kakuda, Keita
	NRID 1000050727451 1000050727451 ORCID 0000-0001-9147-8058 0000-0001-9147-8058 researchmap permalink y-kimura_neurol y-kimura_neurol Scopus Author ID 56673363900 56673363900 著者名 Kimura, Yasuyoshi
	NRID 1000090230044 1000090230044 ORCID 0000-0002-0874-7542 0000-0002-0874-7542 researchmap permalink read0207787 read0207787 Scopus Author ID 7202006099 7202006099 著者名 Mochizuki, Hideki
キーワード等	biomarker
	COMT inhibitor
	Levodopa-Carbidopa Intestinal Gel Infusion
	Opicapone
	Parkinson's disease
	vitamin B6
内容	Ikenaka K., Kajiyama Y., Aguirre C., et al. Decreased hepatic enzymes reflect the decreased vitamin B6 levels in Parkinson's disease patients. Pharmacology Research and Perspectives 12, e1174 (2024); https://doi.org/10.1002/prp2.1174.
抄録	The study aims to investigate the vitamin B6 levels in Parkinson's disease (PD) patients and their association with liver enzymes and evaluate how much dysregulation is associated with levodopa dose. Furthermore, to evaluate the effect of Opicapone, a catechol-o-methyl-transferase inhibitor, on vitamin B6 levels by monitoring the AST and ALT levels in patients treated with Levodopa–Carbidopa Intestinal Gel Infusion (LCIG). For these aims, serum vitamin B6 levels were measured (PD, n = 72 and controls, n = 31). The vitamin B6 level was compared with the total levodopa dose, clinical parameters, and blood homocysteine, albumin, and hemoglobin levels in PD patients. Correlations between vitamin B6 levels and AST and ALT levels, as well as the ratio ALT/AST, were analyzed. Changes in the AST and ALT levels and ALT/AST were analyzed in the patients treated with LCIG before and after the therapy (n = 24) and in the patients treated with LCIG + Opicapone before and after Opicapone treatment (n = 12). We found vitamin B6 levels were significantly lower in PD patients. Total levodopa dose and albumin levels were independently associated with vitamin B6 levels. Decreased vitamin B6 levels appeared as lower AST and ALT levels and ALT/AS. Treatment with LCIG decreased the AST and ALT levels and ALT/AST. Adjunctive therapy with Opicapone to LCIG ameliorated the decreased ALT and ALT/AST. We conclude that the ALT and ALT/AST can be useful parameters for monitoring vitamin B6 levels and Opicapone can ameliorate the dysregulated vitamin B6 in PD patients.
出版者	John Wiley and Sons Inc
収録物名	Pharmacology Research and Perspectives
巻(号)	12(1)
ページ	e1174
刊行年月	2024-02-01
言語	英語
ハンドルURL	https://hdl.handle.net/11094/94596
eISSN	20521707
関連情報 (isIdenticalTo)	DOI (出版社版) https://doi.org/10.1002/prp2.1174
アクセス権	open access
権利情報	This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
出版タイプ	Version of Record
カテゴリ	学術雑誌論文 Journal Article

資源タイプ	学術雑誌論文
ローカル資源タイプ	学術雑誌論文
DCMI資源タイプ	text
DCTERMS.bibliographicCitation	Pharmacology Research and Perspectives. 2024, 12(1), p. e1174
DC.title	Decreased hepatic enzymes reflect the decreased vitamin B6 levels in Parkinson's disease patients
DC.creator	Ikenaka, Kensuke
	Kajiyama, Yuta
	Aguirre, César
	Choong, Chi Jing
	Taniguchi, Seira
	Doi, Junko
	Wang, Nan
	Ajiki, Takahiro
	Ogawa, Kotaro
	Kakuda, Keita
	Kimura, Yasuyoshi
	Mochizuki, Hideki
DC.publisher	John Wiley and Sons Inc
DC.language' scheme='DCTERMS.RFC1766	英語
DC.type' scheme='DCTERMS.DCMIType	text
DCTERMS.issued' scheme='DCTERMS.W3CDTF	2024-02-01
DC.identifier	https://doi.org/10.1002/prp2.1174
DC.subject	biomarker
	COMT inhibitor
	Levodopa-Carbidopa Intestinal Gel Infusion
	Opicapone
	Parkinson's disease
	vitamin B6
DC.description	Ikenaka K., Kajiyama Y., Aguirre C., et al. Decreased hepatic enzymes reflect the decreased vitamin B6 levels in Parkinson's disease patients. Pharmacology Research and Perspectives 12, e1174 (2024); https://doi.org/10.1002/prp2.1174.
DCTERMS.abstract	The study aims to investigate the vitamin B6 levels in Parkinson's disease (PD) patients and their association with liver enzymes and evaluate how much dysregulation is associated with levodopa dose. Furthermore, to evaluate the effect of Opicapone, a catechol-o-methyl-transferase inhibitor, on vitamin B6 levels by monitoring the AST and ALT levels in patients treated with Levodopa–Carbidopa Intestinal Gel Infusion (LCIG). For these aims, serum vitamin B6 levels were measured (PD, n = 72 and controls, n = 31). The vitamin B6 level was compared with the total levodopa dose, clinical parameters, and blood homocysteine, albumin, and hemoglobin levels in PD patients. Correlations between vitamin B6 levels and AST and ALT levels, as well as the ratio ALT/AST, were analyzed. Changes in the AST and ALT levels and ALT/AST were analyzed in the patients treated with LCIG before and after the therapy (n = 24) and in the patients treated with LCIG + Opicapone before and after Opicapone treatment (n = 12). We found vitamin B6 levels were significantly lower in PD patients. Total levodopa dose and albumin levels were independently associated with vitamin B6 levels. Decreased vitamin B6 levels appeared as lower AST and ALT levels and ALT/AS. Treatment with LCIG decreased the AST and ALT levels and ALT/AST. Adjunctive therapy with Opicapone to LCIG ameliorated the decreased ALT and ALT/AST. We conclude that the ALT and ALT/AST can be useful parameters for monitoring vitamin B6 levels and Opicapone can ameliorate the dysregulated vitamin B6 in PD patients.
DC.rights	This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
DC.format	94596
citation_title	Decreased hepatic enzymes reflect the decreased vitamin B6 levels in Parkinson's disease patients
citation_author	Ikenaka, Kensuke
	Kajiyama, Yuta
	Aguirre, César
	Choong, Chi Jing
	Taniguchi, Seira
	Doi, Junko
	Wang, Nan
	Ajiki, Takahiro
	Ogawa, Kotaro
	Kakuda, Keita
	Kimura, Yasuyoshi
	Mochizuki, Hideki
citation_publisher	John Wiley and Sons Inc
citation_language	英語
citation_date	2024-02-01
citation_journal_title	Pharmacology Research and Perspectives
citation_volume	12
citation_issue	1
citation_firstpage	e1174
citation_doi	https://doi.org/10.1002/prp2.1174
citation_public_url	https://hdl.handle.net/11094/94596

Decreased hepatic enzymes reflect the decreased vitamin B6 levels in Parkinson's disease patients

閲覧可能ファイル

論文情報

論文詳細を表示